NEOGEN CORP (NEOG) Fundamental Analysis & Valuation

NASDAQ:NEOG • US6404911066

Current stock price

10.005 USD
-0.33 (-3.24%)
Last:

This NEOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NEOG Profitability Analysis

1.1 Basic Checks

  • NEOG had positive earnings in the past year.
  • In the past year NEOG had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NEOG reported negative net income in multiple years.
  • Each year in the past 5 years NEOG had a positive operating cash flow.
NEOG Yearly Net Income VS EBIT VS OCF VS FCFNEOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -17.94%, NEOG is in line with its industry, outperforming 52.13% of the companies in the same industry.
  • NEOG has a Return On Equity of -28.64%. This is comparable to the rest of the industry: NEOG outperforms 55.32% of its industry peers.
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROIC N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
NEOG Yearly ROA, ROE, ROICNEOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • NEOG has a worse Gross Margin (45.98%) than 60.64% of its industry peers.
  • In the last couple of years the Gross Margin of NEOG has remained more or less at the same level.
  • NEOG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
NEOG Yearly Profit, Operating, Gross MarginsNEOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NEOG Health Analysis

2.1 Basic Checks

  • NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NEOG remains at a similar level compared to 1 year ago.
  • NEOG has more shares outstanding than it did 5 years ago.
  • NEOG has a worse debt/assets ratio than last year.
NEOG Yearly Shares OutstandingNEOG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NEOG Yearly Total Debt VS Total AssetsNEOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • NEOG has an Altman-Z score of 1.25. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.
  • NEOG has a Altman-Z score of 1.25. This is comparable to the rest of the industry: NEOG outperforms 50.53% of its industry peers.
  • NEOG has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • NEOG's Debt to Equity ratio of 0.38 is in line compared to the rest of the industry. NEOG outperforms 46.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACCN/A
WACC8.14%
NEOG Yearly LT Debt VS Equity VS FCFNEOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • NEOG has a Current Ratio of 3.91. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
  • NEOG has a Current ratio of 3.91. This is in the better half of the industry: NEOG outperforms 63.30% of its industry peers.
  • NEOG has a Quick Ratio of 2.80. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
  • NEOG's Quick ratio of 2.80 is fine compared to the rest of the industry. NEOG outperforms 61.17% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 2.8
NEOG Yearly Current Assets VS Current LiabilitesNEOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NEOG Growth Analysis

3.1 Past

  • The earnings per share for NEOG have decreased strongly by -27.50% in the last year.
  • The earnings per share for NEOG have been decreasing by -10.20% on average. This is quite bad
  • Looking at the last year, NEOG shows a decrease in Revenue. The Revenue has decreased by -3.67% in the last year.
  • NEOG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.43% yearly.
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%

3.2 Future

  • NEOG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.29% yearly.
  • The Revenue is expected to decrease by -0.50% on average over the next years.
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NEOG Yearly Revenue VS EstimatesNEOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
NEOG Yearly EPS VS EstimatesNEOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. NEOG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 34.50, the valuation of NEOG can be described as expensive.
  • Based on the Price/Earnings ratio, NEOG is valued a bit cheaper than 70.74% of the companies in the same industry.
  • NEOG is valuated rather expensively when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 29.50, the valuation of NEOG can be described as expensive.
  • NEOG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NEOG is cheaper than 71.81% of the companies in the same industry.
  • NEOG is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.5
Fwd PE 29.5
NEOG Price Earnings VS Forward Price EarningsNEOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 68.62% of the companies in the same industry are more expensive than NEOG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.8
NEOG Per share dataNEOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.38%
EPS Next 3Y9.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEOG Dividend Analysis

5.1 Amount

  • NEOG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEOG Fundamentals: All Metrics, Ratios and Statistics

NEOGEN CORP

NASDAQ:NEOG (4/9/2026, 1:16:05 PM)

10.005

-0.33 (-3.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-09
Earnings (Next)N/A
Inst Owners104.06%
Inst Owner Change0.01%
Ins Owners0.65%
Ins Owner Change24.72%
Market Cap2.18B
Revenue(TTM)880.32M
Net Income(TTM)-602.74M
Analysts78.18
Price Target11.22 (12.14%)
Short Float %4.19%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.17%
Min EPS beat(2)78.25%
Max EPS beat(2)96.08%
EPS beat(4)2
Avg EPS beat(4)32.2%
Min EPS beat(4)-34.64%
Max EPS beat(4)96.08%
EPS beat(8)3
Avg EPS beat(8)11.3%
EPS beat(12)5
Avg EPS beat(12)119.18%
EPS beat(16)6
Avg EPS beat(16)37.27%
Revenue beat(2)2
Avg Revenue beat(2)3.22%
Min Revenue beat(2)0.46%
Max Revenue beat(2)5.99%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-3.66%
Max Revenue beat(4)5.99%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)0%
PT rev (3m)44.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.69%
EPS NY rev (1m)0%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.31%
Valuation
Industry RankSector Rank
PE 34.5
Fwd PE 29.5
P/S 2.47
P/FCF N/A
P/OCF 32.87
P/B 1.03
P/tB N/A
EV/EBITDA 32.8
EPS(TTM)0.29
EY2.9%
EPS(NY)0.34
Fwd EY3.39%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.3
OCFY3.04%
SpS4.05
BVpS9.67
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.95
Profitability
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.98%
FCFM N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 8.98
Cap/Depr 71.99%
Cap/Sales 9.62%
Interest Coverage N/A
Cash Conversion 74.97%
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 2.8
Altman-Z 1.25
F-Score4
WACC8.14%
ROIC/WACCN/A
Cap/Depr(3y)85.8%
Cap/Depr(5y)97.5%
Cap/Sales(3y)10.58%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%
EBIT growth 1Y-193.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.34%
EBIT Next 3Y34.61%
EBIT Next 5Y20.01%
FCF growth 1Y-209.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.22%
OCF growth 3Y-5.05%
OCF growth 5Y-7.47%

NEOGEN CORP / NEOG Fundamental Analysis FAQ

What is the fundamental rating for NEOG stock?

ChartMill assigns a fundamental rating of 3 / 10 to NEOG.


What is the valuation status of NEOGEN CORP (NEOG) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEOGEN CORP (NEOG). This can be considered as Overvalued.


Can you provide the profitability details for NEOGEN CORP?

NEOGEN CORP (NEOG) has a profitability rating of 2 / 10.


How financially healthy is NEOGEN CORP?

The financial health rating of NEOGEN CORP (NEOG) is 4 / 10.


Can you provide the expected EPS growth for NEOG stock?

The Earnings per Share (EPS) of NEOGEN CORP (NEOG) is expected to decline by -9.33% in the next year.